Skip to main content
. 2022 Jun 16;14(12):2965. doi: 10.3390/cancers14122965

Figure 2.

Figure 2

Schematic representation and positioning of pioneering drugs for treating multiple myeloma over the years (arrow). For each typology of drugs, the most representative compounds with their corresponding commercial names are reported in the specific boxes.